According to a market report by Lucintel, the future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $20 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in hormonal contraceptive market to 2030 by method
(pill, intrauterine device, injectable, vaginal ring, implant, and patch),
hormone (combination hormonal contraceptive and progestin only), and region
(North America, Europe, Asia Pacific, and the Rest of the World).
In this market, pill, intrauterine device , injectable, vaginal ring,
implant, and patch are the major segments of hormonal contraceptive market by
method. Lucintel forecasts that pill will remain the largest segment over the
forecast period due to increasing awareness about the pills.
Within this market, combination hormonal contraceptive will remain the
larger segment.
Download sample by clicking on hormonal
contraceptive market
APAC is expected to witness highest growth over the forecast period due
to presence of large pool target population and rise in investment by key
players in the region.
AbbVie, Afaxys, Teva Pharmaceuticals Industries, Bayer, Organon, Pfizer,
Agile Therapeutics, Janssen Pharmaceutical, Lupin Pharmaceutical, and Pregna
International are the major suppliers in the hormonal contraceptive market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Anti-Slip
Coating Market in Canada
Bioplastic
Textile Market in Canada
Castor Oil
& Derivative Market in Canada
No comments:
Post a Comment